Literature DB >> 15243162

Immune response to Leishmania infection.

Amit Awasthi1, Ram Kumar Mathur, Bhaskar Saha.   

Abstract

Antileishmanial immune response is shown to be host genotype dependent so that some inbred strains of mouse are susceptible while others are resistant. The resistance is conferred by T-helper type-1 (Th1) cells while the susceptibility is conferred by Th2 cells. Th1 cells secrete IL-2 and IFN-gamma but Th2 cells secrete IL-4, IL-5 and IL-10. It has been shown that IFN-gamma activates macrophages to express iNOS2, the enzyme catalyzing the formation of nitric oxide. Nitric oxide kills the intracellular amastigotes. In contrast, Th2 immune response limits the action of Th1 functions via IL-10 and IL-4, which deactivate macrophages helping intracellular parasite growth and disease progression. Being a parasite, Leishmania ensures its own survival by modulating host immune system either by inducing immunosuppression or by promoting pro-parasitic host functions. A detailed knowledge of this host-parasite interaction would help in designing prophylactic and therapeutic strategies against this infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243162

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  56 in total

1.  In vitro antileishmanial activity of Aloe vera leaf exudate: a potential herbal therapy in leishmaniasis.

Authors:  Avijit Dutta; Goutam Mandal; Chitra Mandal; Mitali Chatterjee
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

2.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

3.  Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.

Authors:  Fernando Tobias Silveira; Ralph Lainson; Adelson Alcimar Almeida De Souza; Marliane Batista Campos; Liliane Almeida Carneiro; Luciana Vieira Rego Lima; Patrícia Karla Santos Ramos; Cláudia Maria de Castro Gomes; Marcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2009-11-28       Impact factor: 2.289

4.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

5.  Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.

Authors:  Catherine S Nation; Blaise Dondji; Gabrielle A Stryker
Journal:  Parasitol Res       Date:  2012-04-04       Impact factor: 2.289

6.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

7.  The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.

Authors:  Gunjan Sharma; Susanta Kar; Writoban Basu Ball; Kuntal Ghosh; Pijush K Das
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

8.  Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.

Authors:  Maryam Shahi; Masoud Mohajery; Seyyed Ali Akbar Shamsian; Hossein Nahrevanian; Seyyed Mohammad Javad Yazdanpanah
Journal:  Rep Biochem Mol Biol       Date:  2013-04

9.  Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.

Authors:  Tejinder Kaur; Prerna Makkar; Kulbir Randhawa; Sukhbir Kaur
Journal:  Parasitol Res       Date:  2012-09-09       Impact factor: 2.289

10.  Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.

Authors:  Rakhee Sachdeva; Akhil C Banerjea; Nancy Malla; Mohan Lal Dubey
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.